Hydra Biosciences, Inc.
Hydra Biosciences, Inc. Patent applications | ||
Patent application number | Title | Published |
---|---|---|
20160038499 | COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO TRPA1 - Compounds and compositions for treating disorders related to TRPA1 are described herein. | 02-11-2016 |
20150352115 | COMPOUNDS USEFUL FOR TREATING INJURIES FROM WARFARE AGENTS - Compounds and compositions for treating disorders related to TRPA1 are described herein. | 12-10-2015 |
20150299225 | COMPOUNDS FOR MODULATING TRPV3 FUNCTION - The present application relates to compounds and methods for treating pain and other conditions related to TRPV3. | 10-22-2015 |
20140303192 | COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES - Compounds and compositions for treating injuries caused by exposure to chemical warfare agents are described herein. | 10-09-2014 |
20140275528 | SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF - Compounds, compositions and methods are described for inhibiting the TRPC5 ion channel and disorders related to TRPC5. | 09-18-2014 |
20140275071 | SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF - Compounds, compositions and methods are described for inhibiting the TRPC5 ion channel and disorders related to TRPC5. | 09-18-2014 |
20140221401 | METHODS AND COMPOSITIONS FOR TREATING PAIN - The present application relates to compounds and methods for treating pain, incontinence and other conditions. | 08-07-2014 |
20140155417 | COMPOUNDS FOR MODULATING TRPV3 FUNCTION - The present application relates to compounds and methods for treating pain and other conditions related to TRPV3. | 06-05-2014 |
20140100230 | METHODS AND COMPOSITIONS FOR TREATING ANXIETY - Methods of treating a TRPC5 mediated disorder in a subject by administering an effective amount of a TRPC5 antagonist, such as a compound disclosed herein, are described. | 04-10-2014 |
20140011840 | Compounds of Modulating TRPV3 Function - The present application relates to compounds and methods for treating pain and other conditions related to TRPV3. | 01-09-2014 |
20140005208 | COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO TRPA1 | 01-02-2014 |
20130303521 | COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES - Compounds and compositions for treating injuries caused by exposure to chemical warfare agents are described herein. | 11-14-2013 |
20130165454 | COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WAREFARE AGENT-INDUCED INJURIES - Compounds and compositions for treating injuries caused by exposure to chemical warfare agents are described herein. | 06-27-2013 |
20130165427 | COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES - Compounds and compositions for treating injuries caused by exposure to chemical warfare agents are described herein. | 06-27-2013 |
20120015979 | Compounds for Modulating TRPV3 Function - The present application relates to compounds and methods for treating pain and other conditions related to TRPV3. | 01-19-2012 |
20110151559 | Compounds for Modulating TRPV3 Function - The present application relates to compounds and methods for treating pain and other conditions related to TRPV3. | 06-23-2011 |
20110144135 | Compounds for Modulating TRPV3 Function - The present application relates to compounds and methods for treating pain and other conditions related to TRPV3. | 06-16-2011 |
20100273777 | Compounds for Modulating TRPV3 Function - The present application relates to compounds and methods for treating pain and other conditions related to TRPV3. | 10-28-2010 |
20100152209 | Compounds for Modulating TRPV3 Function - The present application relates to compounds and methods for treating pain and other conditions related to TRPV3. | 06-17-2010 |
20090018147 | Compounds for modulating TRPV3 function - The present application relates to compounds and methods for treating pain and other conditions related to TRPV3. | 01-15-2009 |
20080311578 | System for screening eukaryotic membrane proteins - The present invention provides methods and compositions for expressing eukaryotic membrane proteins. | 12-18-2008 |